MRD-negative duration following latest line of therapy predicts long-term PFS in real-world patients with multiple myeloma.

Lucia Y Chen,

Santiago Thibaud,

Saoirse Bodnar,

Ajai Chari,

Joshua Richter,

Hearn Jay Cho,

Larysa J Sanchez,

Cesar Rodriguez,

Adriana C Rossi,

Shambavi Richard,

Samir Parekh,

Sundar Jagannath